DrugPatentWatch Database Preview
ASPIRIN Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Aspirin, and what generic alternatives are available?
Aspirin is a drug marketed by Amneal Pharms, Ani Pharms Inc, Barr, Dr Reddys, Glenmark Pharms Sa, Lannett Co Inc, Par Pharm Inc, Sandoz Inc, Sun Pharm, and Zydus Pharms. and is included in ten NDAs.
The generic ingredient in ASPIRIN is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
Summary for ASPIRIN
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ASPIRIN |
| Drug Sales Revenues: | Drug sales revenues for ASPIRIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ASPIRIN |
| DailyMed Link: | ASPIRIN at DailyMed |
Medical Subject Heading (MeSH) Categories for ASPIRIN
US Patents and Regulatory Information for ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 206392-001 | Mar 8, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Par Pharm Inc | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 207944-001 | Jan 18, 2017 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Dr Reddys | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 209048-001 | Oct 10, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
